Kwanan nan, an fara amfani da sabon ɗakin tiyata na Asibitin Magungunan Gargajiya na Zhucheng a hukumance. An ƙara wani babban injin dijital na angiography (DSA) - sabon tsarin ARTIS mai hawa biyu mai hawa bakwai mai tsayin ƙafa bakwai wanda Siemens na Jamus ya samar don taimakawa asibitin a tiyatar shiga tsakani. Fasahar ganewar asali da magani ta kai wani sabon mataki. Wannan kayan aikin yana da kayan aiki na zamani kamar hoton girma uku, nunin stent, da matakan ƙasan gaɓɓai. Yana iya cika cikakkun buƙatun magani na asibiti na shiga tsakani na zuciya, shiga tsakani na jijiyoyi, shiga tsakani na jijiyoyin jini na gefe, da kuma shiga tsakani na gaba ɗaya na ciwon daji, wanda ke ba wa likitoci damar magance cututtuka mafi ƙarfi da sauƙi. A cikin ƙasa da wata guda tun lokacin da aka fara aiki, an kammala shari'o'i sama da 60 na maganin shiga tsakani don cututtukan zuciya, jijiyoyi, na gefe da na ƙari, kuma an sami sakamako mai kyau.
"Kwanan nan, sashenmu na zuciya da jijiyoyin jini ya kammala ayyukan tiyatar zuciya da jijiyoyin jini sama da 20 ta amfani da sabon tsarin angiography da aka gabatar. Yanzu, ba wai kawai za mu iya yin tiyatar zuciya da jijiyoyin jini da kuma fadada balan-balan na zuciya ba, har ma da yin gwajin electrophysiological na zuciya, maganin rage karfin rediyo da kuma maganin cututtukan zuciya da aka haifa a lokacin haihuwa. "Wang Shujing, darektan Sashen Cututtukan Zuciya da Jijiyoyin Jini, ya ce amfani da sabuwar na'urar ya inganta karfin maganin zuciya gaba daya, wanda ba wai kawai ya biya bukatun marasa lafiya ba, har ma ya sa cututtukan zuciya su fi tasiri. Fasahar ganewar asali da magani ta sashen ta kai matakin ci gaba a cikin gida.
"Gabatar da wannan kayan aikin ya rama kurakuran fasaha na sashen encephalology. Yanzu, ga marasa lafiya da ke fama da bugun zuciya kwatsam, za mu iya narke da kuma cire thrombosis, kuma babu wasu shinge na fasaha kuma." Yu Bingqi, darektan sashen encephalology, ya ce cikin farin ciki, Bayan an kunna kayan aikin, sashen encephalology ya kammala aikin tiyatar cerebrovascular guda 26 cikin nasara. Tare da tallafin wannan kayan aikin, sashen encephalology zai iya yin aikin arteriography na kwakwalwa gaba ɗaya, cikewar aneurysm a cikin cranial, thrombolysis na kwakwalwa mai tsanani a cikin intracatheter da thrombolysis, da kuma thrombolysis na mahaifa. An yi amfani da dabarun kamar dasa stent don stenosis na jijiyoyin jini da kuma embolization na arteriovenous malformation kwanan nan don samun nasarar cire thrombus ga majiyyaci da ke fama da atrial fibrillation wanda ke da emboli da aka cire yana toshe tsakiyar jijiyar kwakwalwa, yana ceton rayuwarsa, yana kiyaye aikin gaɓoɓinsa, da kuma ƙirƙirar abin al'ajabi na rayuwa.
Mataimakin Shugaban Kasa Wang Jianjun ya gabatar da cewa Asibitin Magungunan Gargajiya na kasar Sin ya shafe kusan shekaru 30 yana bunkasa fasahar gano cututtuka da kuma magance su, kuma yana daya daga cikin asibitoci na farko da suka fara gudanar da maganin. Ya kuma tara kwarewa sosai a fannin aikin jiyya na tsawon sama da shekaru 20. Tare da bunkasa sabbin dakunan tiyata, an kara fadada iyakokin gano cututtuka da kuma magance su a asibitinmu, kuma an inganta tasirin maganin sosai. Ta hanyar rage lokacin da ake dauka daga asibiti zuwa lokacin da ake daukar magani na gaggawa, lokacin jira ga marasa lafiya da cututtukan zuciya da jijiyoyin jini don yin gwaje-gwaje masu dacewa zai ragu sosai, musamman lokacin da ake dauka ga marasa lafiya da cututtukan zuciya da jijiyoyin jini masu tsanani kamar subarachnoid hemorrhage da kuma toshewar jijiyoyin jini da kuma thrombocytopectomy, wanda hakan zai rage mace-mace da nakasa ga marasa lafiya, ta haka zai hanzarta yawan dawowa, rage yawan kwanaki na asibiti, da kuma rage kudaden da ake kashewa wajen asibiti. A lokaci guda kuma, ya inganta matakin gaggawa na asibitin wajen magance cututtukan zuciya da jijiyoyin jini, ya kuma inganta ingancin ceto ga marasa lafiya, ya kuma sa hanyoyin samun sauki su yi aiki, sannan ya kara inganta ingancin ginin cibiyar ciwon kirji da cibiyar bugun jini ta asibitin.
————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————–
Wannanlabaraidaga sashen labarai na gidan yanar gizon hukuma na LnkMed.LnkMedmasana'anta ce da ta ƙware wajen haɓakawa da samar da allurar allurar contrast agent mai matsin lamba don amfani da manyan na'urori masu auna sigina. Tare da haɓaka masana'antar, LnkMed ta yi haɗin gwiwa da wasu masu rarraba magunguna na cikin gida da na ƙasashen waje, kuma an yi amfani da kayayyakin sosai a manyan asibitoci. Kayayyaki da ayyukan LnkMed sun sami amincewar kasuwa. Kamfaninmu kuma zai iya samar da samfuran amfani daban-daban. LnkMed zai mai da hankali kan samar daCT allurar guda ɗaya,CT mai allurar kai biyu,Injin MRI mai nuna bambanci,Injin allurar maganin bambanci mai matsin lamba mai ƙarfi na Angiographyda kuma kayayyakin amfani, LnkMed yana ci gaba da inganta inganci don cimma burin "ba da gudummawa ga fannin ganewar asibiti, don inganta lafiyar marasa lafiya".
Lokacin Saƙo: Afrilu-22-2024
